Posted by Michael Wonder on 06 Nov 2017
EMA publishes agenda for 6-9 November CHMP meeting
6 November 2017 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Rurioctocog alfa
- Darunavir ethanolate
- Benralizumab
- Fulvestrant
- Prasterone
- Budesonide
- Letermovir
- Bevacizumab
- Ocrelizumab
- Semaglutide
- Rucaparib camsylate
